Quoin Pharmaceuticals Ltd. SEC filings QNRX

Quoin Pharmaceuticals Ltd. has 583 filings in SEC EDGAR's recent list, going back to Apr 8, 2016. Its latest annual report, Form ARS, was filed on Jul 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (material agreement).

Form Description Filed Period
DEF 14A Proxy statement Oct 2, 2026 Nov 12, 2026
PRE 14A Preliminary proxy statement Sep 22, 2026 Nov 12, 2026
DEF 14A Proxy statement Jul 16, 2026 Aug 20, 2026
PRE 14A Preliminary proxy statement Jul 6, 2026 Aug 20, 2026
DEF 14A Proxy statement Jul 17, 2025 Aug 21, 2025
PRE 14A Preliminary proxy statement Jul 7, 2025 Aug 21, 2025
DEF 14A Proxy statement Oct 24, 2024 Dec 5, 2024
PRE 14A Preliminary proxy statement Oct 11, 2024 Dec 5, 2024
DEFA14A Additional proxy material Apr 2, 2024 —
DEF 14A Proxy statement Feb 27, 2024 Mar 29, 2024
PRE 14A Preliminary proxy statement Feb 13, 2024 Mar 29, 2024
DEFA14A Additional proxy material Oct 19, 2023 —
DEF 14A Proxy statement Sep 12, 2023 Oct 19, 2023
PRE 14A Preliminary proxy statement Sep 1, 2023 Sep 1, 2023

Showing 14 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
QNRX (Nasdaq)
Incorporated in
Israel
Headquarters
Ashburn, VA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1671502
Former names
Quoin Pharmaceuticals, Ltd. (until Sep 1, 2026); Cellect Biotechnology Ltd. (until Oct 15, 2021); Cellect Biomed Ltd. (until Jul 7, 2016)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.